Middle East & Africa Newborn Screening Market Size & Outlook
Middle East & Africa newborn screening market, 2018-2030 (US$M)
Related Markets
MEA newborn screening market highlights
- The MEA newborn screening market generated a revenue of USD 94.5 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 94.5 million |
| Market revenue in 2030 | USD 158.2 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 11.8% of the global newborn screening market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 451.1 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.55% in 2023. Horizon Databook has segmented the Middle East & Africa newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
For Middle Eastern countries, pediatric morbidity is a major concern, particularly due to rising case of consanguinity-associated deaths. The region is still under development and the program requires extra efforts due to lack of funds, trained physicians, and absence of good infrastructures.
In order to combat the situation, the Supreme Council of Health in Qatar initiated a conference for countries of Middle East and North Africa. The motto of the conference was to introduce opportunities for the region in the form of research collaborations along with strengthening of healthcare infrastructure.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA newborn screening market size, by country, 2018-2030 (US$M)
Middle East & Africa Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
